271 related articles for article (PubMed ID: 8517457)
1. Sources of regulatory information for pharmacists.
Goldwire MA; Rumore MM
Am J Hosp Pharm; 1993 Jun; 50(6):1175-81. PubMed ID: 8517457
[TBL] [Abstract][Full Text] [Related]
2. Investigational drug tracking: Phases I-III and NDA submissions--Part I.
Grant KL
Hosp Pharm; 1994 Sep; 29(9):830-6, 839-44, 847-52 passim. PubMed ID: 10137064
[TBL] [Abstract][Full Text] [Related]
3. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
4. Investigational drug tracking: phases I-III and NDA submissions--Part II.
Grant KL
Hosp Pharm; 1994 Oct; 29(10):900, 902-4, 906-11 passim. PubMed ID: 10137850
[TBL] [Abstract][Full Text] [Related]
5. Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jul; 73(136):40453-63. PubMed ID: 18850678
[TBL] [Abstract][Full Text] [Related]
6. Regulatory aspects of investigational new drugs.
Arbit HM
Am J Hosp Pharm; 1978 Jan; 35(1):81-5. PubMed ID: 341700
[TBL] [Abstract][Full Text] [Related]
7. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
Kock M; Thomsen MK
Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
[TBL] [Abstract][Full Text] [Related]
8. Economics of new oncology drug development.
DiMasi JA; Grabowski HG
J Clin Oncol; 2007 Jan; 25(2):209-16. PubMed ID: 17210942
[TBL] [Abstract][Full Text] [Related]
9. Physician dispensing: issues of law, legislation and social policy.
Abood RR
Am J Law Med; 1989; 14(4):307-52. PubMed ID: 2729291
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
[TBL] [Abstract][Full Text] [Related]
11. A physician's guide to information available from the FDA about new drug approvals. The ACG Committee on FDA-related matters. American College of Gastroenterology.
Hassall TH; Fredd SB
Am J Gastroenterol; 1989 Oct; 84(10):1222-6. PubMed ID: 2801669
[TBL] [Abstract][Full Text] [Related]
12. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
Chodock R; Yolkut D; Connolly DR
Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
[TBL] [Abstract][Full Text] [Related]
13. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
Sayeed SA
Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
[TBL] [Abstract][Full Text] [Related]
14. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
Mackler BF; Barach M
J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigation.
Zalesky CD
J Health Law; 2006; 39(2):235-64. PubMed ID: 17002233
[TBL] [Abstract][Full Text] [Related]
16. Failure of enforcement controlled substance laws in health policy for prescribing opiate medications: a painful assessment of morbidity and mortality.
Miller NS
Am J Ther; 2006; 13(6):527-33. PubMed ID: 17122534
[TBL] [Abstract][Full Text] [Related]
17. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
[TBL] [Abstract][Full Text] [Related]
18. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
19. Computer-assisted investigational drug information and testing mechanism for nurses.
Wermeling DP; Nowak-Rapp M; Sitzlar S
Hosp Pharm; 1994 Aug; 29(8):745-6, 748-50. PubMed ID: 10135743
[TBL] [Abstract][Full Text] [Related]
20. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]